仿制药肿瘤药物市场概况、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPRE00006393
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Generic Oncology Drugs Market Research Report 2021-2031

Buy Now

肿瘤仿制药市场规模预计2022年为247.8亿美元,2023年为XX亿美元,预计到2031年将达到424.3亿美元;预计到 2031 年,复合年增长率将达到 6.3%。政府治疗癌症的举措可能仍然是仿制药市场的主要趋势。

 

仿制药市场分析

根据VOXEU发布的一份报告,随着全球医疗保健预算面临压力,转向品牌仿制药似乎自然可以节省成本。肿瘤学仿制药是品牌药物的更便宜的替代品,可为任何医疗保健系统提供效率提升。随着肿瘤药物管道的萎缩以及许多肿瘤药物专利即将到期,肿瘤仿制药的产量迅速增加。

仿制药在肿瘤学中很重要,因为一些抗癌药物仅作为仿制药提供。在大多数情况下,患有急性淋巴细胞白血病的儿童或患有早期乳腺癌的女性患者都接受仿制药治疗。仿制药广泛用于支持治疗。使用仿制药最显着的好处是成本,比品牌药低 85%。因此,仿制药的渗透率不断上升正在推动市场的增长。 

 

仿制药市场概况

在线科学电子图书馆 ( SciELO ) 报告指出,推广品牌仿制药是各国国家医药政策的核心工具,最终通过扩大医疗保健机会来减少药品支出。例如,为了以实惠的价格提供优质仿制药,印度政府化学品和化肥部制药司于 2008 年 11 月推出了Pradhan Mantri Bhartiya Janaushadhi Pariyojana ( PMBJP )。该计划重点关注称为Janaushadhi Kendras,以实惠的价格提供仿制药。到 2021 年,全国有8,012 个Janaushadhi Kendras在运作。印度政府越来越重视提供治疗包括癌症在内的各种疾病的仿制药,这推动了印度仿制药市场的增长。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

仿制药市场:

仿制药市场
  • Generic Oncology Drugs Market
    年均复合增长率(2023 - 2031)
    6.3%
  • 2022 年市场规模
    247.8 亿美元
  • 2031 年市场规模
    424.3 亿美元

市场动态

增长动力
  • 癌症患病率增加
未来的趋势
  • 倾向于个性化药物
机会
  • 对仿制药的偏好日益增长

关键人物;主力;重要一员

  • 梯瓦制药工业有限公司
  • 山德士国际有限公司
  • 格兰马克制药有限公司
  • 太阳制药工业有限公司
  • MSN实验室
  • 奥罗宾多制药公司
  • 英塔斯制药有限公司
  • 兹杜斯·卡迪拉
  • 迈兰公司
  • 希尔帕医疗保险有限公司

区域概况

Generic Oncology Drugs Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Generic Oncology Drugs Market分子类型
  • 大分子
  • 小分子
Generic Oncology Drugs Market指示
  • 肺癌
  • 胃癌
  • 结直肠癌
  • 乳腺癌
  • 前列腺癌
  • 肝癌
  • 肾癌
  • 宫颈癌
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

仿制药市场驱动因素和机遇

 

癌症负担增加

癌症是全球主要死亡原因之一,极大地影响生活质量。因此,如果不及时诊断和治疗,癌症将成为社会的负担。据世界卫生组织 (WHO) 称,2022 年,约有 2000 万新诊断癌症病例,约 970 万人因癌症死亡。根据同一来源,大约有 5350 万人在癌症诊断后 5 年内存活。为了控制和管理癌症,这些公司正专注于开发仿制药肿瘤药物。因此,癌症患病率的增加和因癌症死亡人数的增加正在推动非专利肿瘤药物市场的增长。

 

个性化医疗的倾向——仿制药市场的机遇

个性化医疗是一种新方法,但在医疗保健领域是一个快速扩展的领域,医生可以根据患者的基因图谱选择治疗方案,这不仅可以最大限度地减少有害副作用,还可以在短时间内获得成功的结果时间。癌症个性化医学涉及对肿瘤生长的个体基因构成的研究。通过研究患者的基因组成,肿瘤学家可以根据患者的基因突变定制治疗方案。例如,ALK、KRAS 和 EGFR 突变会导致肺癌。然而,识别肺癌患者的突变类型为治疗类型提供了重要信息。 在个性化医疗出现之前,所有患者都针对特定类型的癌症接受相同的治疗。然而,随着个性化医疗的出现,患者可以根据他/她的基因组成接受治疗。切除患者的组织以进行基因诊断过程。检查患者的组织样本是否有基因突变,进一步根据突变的类型进行化疗。这样可以在正确的时间进行正确的治疗,从而降低死亡率。由于根据个体基因谱定制治疗的这些优势,个性化医疗方法可能会为仿制药市场创造许多机会。

 

仿制药市场报告细分分析

有助于得出仿制药市场分析的关键部分是解决方案、交付方式、应用和最终用户。

  • 根据分子类型,仿制药市场分为大分子和小分子。 2023 年,小分子细分市场将占据更大的市场份额。
  • 根据情况,仿制药市场分为肺癌、胃癌、结直肠癌、乳腺癌、前列腺癌、肝癌、肾癌、宫颈癌等。 2023 年,胃癌细分市场占据最大市场份额。

 

按地域划分的仿制药市场份额分析

仿制药市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲以及南美洲和中美洲。

北美主导了仿制药肿瘤药物市场。由于各种因素,例如癌症患病率上升、人们对医疗状况的认识不断提高以及支持性协会的存在,预计该地区的市场需求在预测期内将大幅增长。该区域。此外,美国政府正在选择品牌药的廉价版本,这可能会影响非专利肿瘤药物市场。

 

仿制药市场报告范围

报告属性细节
2022年市场规模247.8亿美元
2031 年市场规模424.3亿美元
全球复合年增长率(2023 - 2031)6.3%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按分子类型
  • 大分子
  • 小分子
按指示
  • 肺癌
  • 胃癌
  • 结直肠癌
  • 乳腺癌
  • 前列腺癌
  • 肝癌
  • 肾癌
  • 宫颈癌
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 梯瓦制药工业有限公司
  • 山德士国际有限公司
  • 格兰马克制药有限公司
  • 太阳制药工业有限公司
  • MSN实验室
  • 奥罗宾多制药公司
  • 英塔斯制药有限公司
  • 兹杜斯·卡迪拉
  • 迈兰公司
  • 希尔帕医疗保险有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

仿制药市场新闻和最新动态

仿制药市场是通过收集初级和二级研究后的定性和定量数据进行评估的,其中包括重要的公司出版物、协会数据和数据库。以下是神经介入设备和策略市场发展的列表:

  • Zydus Lifesciences 在印度推出了 PARP 抑制剂奥拉帕尼 (olaparib),商品名为 IBYRA,使所有人都能获得先进的癌症治疗。 PARP(聚 ADP 核糖聚合酶)是一种帮助受损细胞自我修复的蛋白质。作为一种癌症治疗方法,PARP 抑制剂可阻止 PARP 在癌细胞中进行修复工作,从而导致细胞死亡。 (来源:经济时报,新闻稿,2024)
  • Gland Pharma 在美国市场推出癌症治疗药物注射用硼替佐米。该公司已通过合作伙伴在美国市场推出该产品,并获得美国食品药品监督管理局的批准。 (来源:经济时报,新闻稿,2022)

 

非专利肿瘤药物市场报告范围和交付成果

《仿制药市场规模和预测(2021-2031)》报告对以下领域的市场进行了详细分析:

  • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..